2005
DOI: 10.1016/s0012-3692(15)34485-8
|View full text |Cite
|
Sign up to set email alerts
|

Decreased CCAAT/Enhancer Binding Protein Transcription Factor Activity in Chronic Bronchitis and COPD

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
27
0

Year Published

2007
2007
2017
2017

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 16 publications
(31 citation statements)
references
References 19 publications
4
27
0
Order By: Relevance
“…There is a striking overlap, both in human and mouse lung, in the cellular expression pattern of Nod1 (as observed in the present study) and the C/EBP-transcription factors [17,18,25]. Therefore, the activation of C/EBP family members downstream of Nod1 was further investigated by EMSA using antibodies to C/EBPb and C/EBPd.…”
Section: Activation Of Transcription Factors Downstream Of Nod1supporting
confidence: 74%
See 1 more Smart Citation
“…There is a striking overlap, both in human and mouse lung, in the cellular expression pattern of Nod1 (as observed in the present study) and the C/EBP-transcription factors [17,18,25]. Therefore, the activation of C/EBP family members downstream of Nod1 was further investigated by EMSA using antibodies to C/EBPb and C/EBPd.…”
Section: Activation Of Transcription Factors Downstream Of Nod1supporting
confidence: 74%
“…The expression pattern of C/EBPs in the lung has recently been described [17,18,25]. C/EBPb is expressed in airway epithelial cells, as well as alveolar type-II cells and alveolar macrophages, and C/EBPd is found in the airway epithelium and alveolar type-II cells.…”
Section: Discussionmentioning
confidence: 98%
“…A role for C/ EBPs in the regulation of differentiation, proliferation, as well as in inflammation and immunological defenses in other organs and tissues is well established (Poli, 1998;Diamond et al, 2000;Musikacharoen et al, 2001;Ramji and Foka, 2002;Cassel and Nord, 2003), and an increasing amount of evidence implicates C/EBPs in lung diseases (Halmos et al, 2002;Roth et al, 2004;Didon et al, 2005Didon et al, , 2010Didon et al, , 2011Binia et al, 2011). We have previously observed reduced activity of C/EBPb in smokers with chronic obstructive pulmonary disease (COPD) (Didon et al, 2005) as well as reduced expression of C/EBPb in cigarette smokers (Didon et al, 2011), indicating a role for C/ EBPs in COPD pathogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…A role for C/ EBPs in the regulation of differentiation, proliferation, as well as in inflammation and immunological defenses in other organs and tissues is well established (Poli, 1998;Diamond et al, 2000;Musikacharoen et al, 2001;Ramji and Foka, 2002;Cassel and Nord, 2003), and an increasing amount of evidence implicates C/EBPs in lung diseases (Halmos et al, 2002;Roth et al, 2004;Didon et al, 2005Didon et al, , 2010Didon et al, , 2011Binia et al, 2011). We have previously observed reduced activity of C/EBPb in smokers with chronic obstructive pulmonary disease (COPD) (Didon et al, 2005) as well as reduced expression of C/EBPb in cigarette smokers (Didon et al, 2011), indicating a role for C/ EBPs in COPD pathogenesis. In addition, defective C/EBPa signaling is associated with dysfunctional lung maturation (Basseres et al, 2006;Berg et al, 2006;Martis et al, 2006;Didon et al, 2010), reminiscent of the pulmonary immaturity of premature children with bronchopulmonary dysplasia, which may contribute to obstructive symptoms later in life (Vrijlandt et al, 2006;Lum et al, 2011).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation